In October, Zainab Mughal’s parents received some crushing news: Their 2-year-old was diagnosed with neuroblastoma, an aggressive cancer that usually occurs in children.
“The results came in and the results were really bad,” her father, Raheel Mughal, said in a video.
The tumor had been growing inside Zainab’s abdomen for nearly half of her life, doctors said. Fighting it would require two bone marrow transplants and a series of transfusions to replenish her blood supply as chemotherapy shrank the tumor to nothing.
Then the news went from really bad to far worse. Mughal and his wife were tested to see whether they were compatible blood donors. They weren’t. A parade of family members and friends went to the hospital to have their blood tested. No luck.
“And that’s when it became more of an alert,” Mughal said.
Now the 2-year-old is at the center of a worldwide search for donors with the same extremely rare blood who can help her, a battle dependent on statistics and probabilities with which her parents have become all too familiar.
More than 1,000 people of Iranian, Indian or Pakistani descent have donated blood in an attempt to find matches for Zainab.
There are some 360 different antigens on the surface of red blood cells, but most people’s bodies won’t respond negatively to those markers, said Frieda Bright, OneBlood’s reference lab manager. For most people, getting the blood type right is all that matters.
But a small percentage of people — including Zainab — produce antibodies in the presence or absence of certain antigens, prompting the body to reject the blood. But those people still get into accidents or come down with diseases like everyone else, so there’s a network of blood centers that specialize in rare blood, keeping a database of scarce combinations of antibodies and shuttling it across the country to patients in need.
That’s a big part of Bright’s job. She’s part of a team that works around the clock, 365 days a year to identify and catalogue units of rare blood and, when possible, fulfill requests. Still, Zainab’s case is so rare that Bright — who’s worked in the industry for 20 years — had to go to a textbook to learn more about it.
Now OneBlood is working with the American Rare Donor Program, an organization that connects donors with patients in need across the world. For Zainab, three compatible donors have been found — one lives in London, the other two are in the United States.
That’s a promising sign, but it’s not enough. Rules limit how frequently donors can give blood. Zainab’s doctors would have to line up as many as 10 donors to ensure that whenever Zainab needs a blood transfusion, she can get it.
It is the missing piece of a treatment plan that doctors say is already shrinking Zainab’s tumor.
Zainab’s parents and a team of experts realize it’s not over until Zainab walks out of the hospital, cancer free. So they’ve launched an awareness campaign using the best weapons they have: Zainab’s story and an endless stream of adorable — occasionally toothless — baby photos. One shows the toddler wearing a birthday cap and a polka-dot pink dress, another shows her posing for a photo in a cream-colored dress, with flowers and ribbons in her hair. A third, post-diagnosis, shows huge brown eyes beneath a bald head.
She is still too young to fully grasp the gravity of what she needs or the overwhelming odds against her. But her father hopes to one day explain to her how a group of people they did not know helped save her life.
“It’s a humble request, and I request it from my heart,” Mughal said in a video produced by OneBlood. “My daughter’s life very much depends on the blood. …